Patent · US Active

Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia

US11357757B2 · kind B2 · utility

6Cited by

27References

8Claims

0Family size

Assignee

ATROGI AB · SE

Inventor

Benjamin Pelcman · Stockholm, SE

Key dates

Filing date	Sep 13, 2018
Grant date	Jun 14, 2022
Priority date	—
Expiry date	Sep 13, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D277/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the ring containing Q1 to Q5, and the groups R1, R2 and R3, have meanings as provided in the description.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.